Billedbehandlingskomponenten technetium- 99m LeukoScan [technetium- 99m sulesomab] fremstilles ved rekonstituering af indholdet i LeukoScan- hætteglasset med 0, 5 ml natriumkloridinjerktionsvæske efterfulgt af tilsætning af 1100 MBq natriumperteknetat [99mTc] i 1 ml natriumkloridinjektionsvæske.
The imaging agent, technetium-99m LeukoScan [technetium-99m sulesomab] is formed by reconstitution of the contents of the LeukoScan vial with 0.5 mL sodium chloride for injection followed by the addition of 1100 MBq of sodium pertechnetate [99mTc] in 1 mL of Sodium Chloride for Injection.